ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,070,329,787 | -10.4% | 39,437,354 | +1.5% | 0.03% | -7.1% |
Q2 2023 | $1,194,181,249 | -12.6% | 38,847,796 | +2.4% | 0.03% | -20.0% |
Q1 2023 | $1,366,618,585 | -2.9% | 37,930,019 | +6.5% | 0.04% | -7.9% |
Q4 2022 | $1,408,010,301 | +0.3% | 35,627,791 | +1.9% | 0.04% | -7.3% |
Q3 2022 | $1,404,364,000 | +1.7% | 34,951,810 | +6.4% | 0.04% | +5.1% |
Q2 2022 | $1,381,172,000 | +11.3% | 32,853,776 | +3.1% | 0.04% | +34.5% |
Q1 2022 | $1,241,289,000 | +5.1% | 31,860,621 | +7.5% | 0.03% | +7.4% |
Q4 2021 | $1,181,017,000 | +8.8% | 29,636,565 | -1.3% | 0.03% | 0.0% |
Q3 2021 | $1,085,216,000 | +8.8% | 30,028,062 | +23.4% | 0.03% | +8.0% |
Q2 2021 | $997,787,000 | +1.6% | 24,342,200 | +8.1% | 0.02% | -7.4% |
Q1 2021 | $981,999,000 | +966.9% | 22,512,593 | +1124.2% | 0.03% | +800.0% |
Q4 2020 | $92,041,000 | +54.8% | 1,838,966 | +30.2% | 0.00% | +50.0% |
Q3 2020 | $59,440,000 | -11.5% | 1,412,886 | +2.1% | 0.00% | 0.0% |
Q2 2020 | $67,162,000 | – | 1,383,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
Brown University | 621,759 | $22,470,000 | 3.05% |
Graypoint LLC | 610,584 | $22,067,000 | 2.71% |